<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:og="http://ogp.me/ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:sioc="http://rdfs.org/sioc/ns#" xmlns:sioct="http://rdfs.org/sioc/types#" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" version="2.0" xml:base="https://rtaylor193.github.io/insureintell-1col/">
  <channel>
    <title>type 2 diabetes</title>
    <link>https://rtaylor193.github.io/insureintell-1col/</link>
    <description/>
    <language>en</language>
    
    <item>
  <title>New Developments in Cardiorenal Protection in Type 2 Diabetes Mellitus</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/26246</link>
  <description>&lt;span&gt;New Developments in Cardiorenal Protection in Type 2 Diabetes Mellitus&lt;/span&gt;
&lt;span&gt;&lt;a title="View user profile." href="https://rtaylor193.github.io/insureintell-1col/user/582" lang="" about="https://rtaylor193.github.io/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="" xml:lang=""&gt;matt&lt;/a&gt;&lt;/span&gt;
&lt;span&gt;Tue, 01/28/2020&lt;/span&gt;

            &lt;div&gt;&lt;p&gt;Dr.&lt;/p&gt;&lt;/div&gt;
      
  &lt;div&gt;
    &lt;div&gt;Link&lt;/div&gt;
              &lt;div&gt;&lt;a href="https://rgare.com/knowledge-center/media/articles/new-developments-in-cardiorenal-protection-in-type-2-diabetes-mellitus"&gt;New Developments in Cardiorenal Protection in Type 2 Diabetes Mellitus&lt;/a&gt;&lt;/div&gt;
          &lt;/div&gt;

  &lt;div&gt;
    &lt;div&gt;Tags&lt;/div&gt;
          &lt;div&gt;
              &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/115" hreflang="en"&gt;Insurance Medicine&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/150" hreflang="en"&gt;diabetes&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/236" hreflang="en"&gt;type 2 diabetes&lt;/a&gt;&lt;/div&gt;
              &lt;/div&gt;
      &lt;/div&gt;
</description>
  <pubDate>Tue, 28 Jan 2020 19:45:56 +0000</pubDate>
    <dc:creator>matt</dc:creator>
    <guid isPermaLink="false">26246 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>
<item>
  <title>Critical Implications of NT-pro BNP in Underwriting Type 2 Diabetics</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/25362</link>
  <description>&lt;span&gt;Critical Implications of NT-pro BNP in Underwriting Type 2 Diabetics&lt;/span&gt;
&lt;span&gt;&lt;a title="View user profile." href="https://rtaylor193.github.io/insureintell-1col/user/582" lang="" about="https://rtaylor193.github.io/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="" xml:lang=""&gt;matt&lt;/a&gt;&lt;/span&gt;
&lt;span&gt;Fri, 02/26/2016&lt;/span&gt;

            &lt;div&gt;&lt;p&gt;N Terminal-pro Brain Natriuretic Peptide (NT-pro BNP) is produced by cardiac muscle cells (myocytes) in response to cardiac wall stress and to ischemia as well.&lt;/p&gt;&lt;/div&gt;
      
  &lt;div&gt;
    &lt;div&gt;Tags&lt;/div&gt;
          &lt;div&gt;
              &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/43" hreflang="en"&gt;NT-proBNP&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/236" hreflang="en"&gt;type 2 diabetes&lt;/a&gt;&lt;/div&gt;
              &lt;/div&gt;
      &lt;/div&gt;
</description>
  <pubDate>Fri, 26 Feb 2016 01:12:30 +0000</pubDate>
    <dc:creator>matt</dc:creator>
    <guid isPermaLink="false">25362 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>
<item>
  <title>Clinical Implications of NT-proBNP in Underwriting Type 2 Diabetics</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/25383</link>
  <description>&lt;span&gt;Clinical Implications of NT-proBNP in Underwriting Type 2 Diabetics&lt;/span&gt;
&lt;span&gt;&lt;a title="View user profile." href="https://rtaylor193.github.io/insureintell-1col/user/582" lang="" about="https://rtaylor193.github.io/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="" xml:lang=""&gt;matt&lt;/a&gt;&lt;/span&gt;
&lt;span&gt;Sun, 01/03/2016&lt;/span&gt;

            &lt;div&gt;&lt;p&gt;N Terminal-pro Brain Natriuretic Peptide (NT-pro BNP) is produced by cardiac muscle cells (myocytes) in response to cardiac wall stress and to ischemia as well.&lt;/p&gt;&lt;/div&gt;
      
  &lt;div&gt;
    &lt;div&gt;Link&lt;/div&gt;
              &lt;div&gt;&lt;a href="http://www.munichre.com/site/marclife-mobile/get/documents_E771093465/marclife/assset.marclife/Documents/Press%20%26%20News/Thought%20Leadership/NT-pro-BNP-Lund-WP_onlineFINAL.pdf"&gt;munichre.com&lt;/a&gt;&lt;/div&gt;
          &lt;/div&gt;

  &lt;div&gt;
    &lt;div&gt;Tags&lt;/div&gt;
          &lt;div&gt;
              &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/50" hreflang="en"&gt;mortality&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/43" hreflang="en"&gt;NT-proBNP&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/236" hreflang="en"&gt;type 2 diabetes&lt;/a&gt;&lt;/div&gt;
              &lt;/div&gt;
      &lt;/div&gt;
</description>
  <pubDate>Sun, 03 Jan 2016 14:42:58 +0000</pubDate>
    <dc:creator>matt</dc:creator>
    <guid isPermaLink="false">25383 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>
<item>
  <title>Modest Relation Between HbA1c, Cardiovascular Events</title>
  <link>https://rtaylor193.github.io/insureintell-1col/node/25427</link>
  <description>&lt;span&gt;Modest Relation Between HbA1c, Cardiovascular Events&lt;/span&gt;
&lt;span&gt;&lt;a title="View user profile." href="https://rtaylor193.github.io/insureintell-1col/user/582" lang="" about="https://rtaylor193.github.io/insureintell-1col/user/582" typeof="schema:Person" property="schema:name" datatype="" xml:lang=""&gt;matt&lt;/a&gt;&lt;/span&gt;
&lt;span&gt;Wed, 09/23/2015&lt;/span&gt;

            &lt;div&gt;&lt;p&gt;For patients with type 2 diabetes, hemoglobin A1c (HbA1c) is not significantly associated with cardiovascular events, regardless of clinical manifestation of vascular disea&lt;/p&gt;&lt;/div&gt;
      
  &lt;div&gt;
    &lt;div&gt;Tags&lt;/div&gt;
          &lt;div&gt;
              &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/279" hreflang="en"&gt;cardiovascular disease&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/150" hreflang="en"&gt;diabetes&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/280" hreflang="en"&gt;HbA1-c&lt;/a&gt;&lt;/div&gt;
          &lt;div&gt;&lt;a href="https://rtaylor193.github.io/insureintell-1col/taxonomy/term/236" hreflang="en"&gt;type 2 diabetes&lt;/a&gt;&lt;/div&gt;
              &lt;/div&gt;
      &lt;/div&gt;
</description>
  <pubDate>Wed, 23 Sep 2015 16:10:36 +0000</pubDate>
    <dc:creator>matt</dc:creator>
    <guid isPermaLink="false">25427 at https://rtaylor193.github.io/insureintell-1col</guid>
    </item>

  </channel>
</rss>
